Clinical Trials Logo

Arthritis, Psoriatic clinical trials

View clinical trials related to Arthritis, Psoriatic.

Filter by:

NCT ID: NCT04709354 Completed - Clinical trials for Rheumatoid Arthritis

Clinical and Dermoscopic Comparison of Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriasis Patients' Nails

Start date: January 1, 2021
Phase:
Study type: Observational

This study evaluates the fingernail findings of the rheumatoid arthritis, spondylopathy and psoriatic arthritis patient groups with the fingernails of psoriasis patients clinically and dermatoscopically and investigates the benefit of dermoscopy in the differentiation of these patients.

NCT ID: NCT04673825 Completed - Psoriatic Arthritis Clinical Trials

Monitoring Spondyloarthritis With SpA-Net

TeleSpA
Start date: December 2, 2020
Phase: N/A
Study type: Interventional

Randomized controlled trial to assess the effectiveness and cost-effectiveness of an intervention combining patient initiated care and telemonitoring through the online eHealth platform SpA-Net versus standard care for patients with spondyloarthritis.

NCT ID: NCT04655612 Completed - COVID-19 Clinical Trials

Seroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic Diseases

COVID-RIC1
Start date: December 1, 2020
Phase:
Study type: Observational

The prevalence of SARS-CoV-2 infection in chronic inflammatory rheumatic diseases has not yet been widely reported, and has been evaluated only in symptomatic patient samples. The proportion of asymptomatic or mildly symptomatic patients is unknown, in patients who share common symptoms with CoV-2-SARS infection. Our objective is to describe the prevalence of seroconversion to CoV-2-SARS by consecutive screening in routine care of patients with chronic inflammatory rheumatism with serological testing

NCT ID: NCT04645420 Completed - Psoriatic Arthritis Clinical Trials

Molecular Effects of Apremilast in the Synovium of Psoriatic Arthritis Patients

MEAS
Start date: November 12, 2020
Phase: N/A
Study type: Interventional

This study assess the genomics profiles in synovial biopsies obtained prior to, and 24 weeks after an immunomodulator agent (Apremilast) in patients with active psoriatic arthritis who are naive to treatment with a conventional synthetic DMARDs (such as methotrexate).

NCT ID: NCT04614831 Completed - Clinical trials for Plaque Psoriasis, Psoriatic Arthritis

A Worldwide Survey on the Understanding of Psoriatic Disease Among Patients With Psoriasis and Psoriatic Arthritis

Start date: November 12, 2020
Phase:
Study type: Observational

The study is a Worldwide Survey on the Understanding of Psoriatic Disease among Patients with Psoriasis and Psoriatic Arthritis.

NCT ID: NCT04588623 Completed - Psoriatic Arthritis Clinical Trials

The MEDIPSA Clinical Trial

MEDIPSA
Start date: November 25, 2020
Phase: N/A
Study type: Interventional

The main purpose of this study is to validate the positive effect of "Omnibiotic Stress Repair" on patients with active psoriatic Arthritis.

NCT ID: NCT04587362 Completed - Psoriasis Clinical Trials

The Diagnostic Ultrasound Enthesitis Tool (DUET) Study

DUET
Start date: March 17, 2021
Phase:
Study type: Observational

Psoriatic arthritis (PsA) is a type of joint disease that can lead to severe joint damage and disability within the first few years of the disease. This is why early detection and treatment of the disease is essential to prevent serious joint damage and improve long-term outcomes in these patients. However, there is currently no reliable way to tell the difference between PsA and other types of joint disease. This makes it difficult to detect PsA early. Enthesitis is an inflammation of the area where muscle tendons and ligaments attach to bones. Enthesitis is a key feature in PsA and can be easily detected using ultrasonography. The aim of this research study is to develop a system to evaluate enthesitis using ultrasonography, which can be used as an effective tool in the early detection of PsA. This will help in providing patients with early treatment to prevent further joint damage.

NCT ID: NCT04582084 Completed - Clinical trials for Rheumatoid Arthritis

Assessment of Treatment Safety and Quality of Life in Patients Receiving Etanercept Biosimilar for Autoimmune Arthritis

ASQA
Start date: April 4, 2014
Phase:
Study type: Observational

In this open-label, multi-center, observational, post-marketing surveillance study, patients with ankylosing spondylitis, psoriatic arthritis, or rheumatoid arthritis received biosimilar etanercept 25 mg twice weekly or 50 mg once weekly in real-world settings. Safety and effectiveness of biosimilar etanercept were evaluated in study participants for a duration of up to 12 months.

NCT ID: NCT04553302 Completed - Psoriatic Arthritis Clinical Trials

Comparison of Hand Functions and Wrist Proprioception in Patients With and Without Psoriatic Arthritis

Start date: October 1, 2019
Phase:
Study type: Observational

The purpose of this study is to assess hand functions and wrist joint position sense in patients with and without PsA.

NCT ID: NCT04540809 Completed - Psoriatic Arthritis Clinical Trials

The Effect of Psoriatic Arthritis on the Functions of the Hand

Start date: April 15, 2019
Phase:
Study type: Observational

This study was planned to evaluate the effect of psoriatic arthritis on the strength, proprioception, skill, coordination, and functional condition of the hand and to determine the correlate disease activity with these parameters.